Close Menu

NEW YORK (360Dx) – A team led by researchers at Arizona State University's Biodesign Institute has developed a mass spec-based test for diagnosing and monitoring active tuberculosis.

Detailed in a study published this week in Proceedings of the National Academy of Sciences, the test uses MALDI mass spec combined with an antibody-based target enrichment device to measure the levels of two Mycobacterium tuberculosis peptides.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand.